Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Debt Ratio (2016 - 2026)

Ironwood Pharmaceuticals' Debt Ratio history spans 12 years, with the latest figure at 1.47 for Q4 2025.

  • On a quarterly basis, Debt Ratio rose 34.27% to 1.47 in Q4 2025 year-over-year; TTM through Dec 2025 was 1.47, a 34.27% increase, with the full-year FY2025 number at 1.47, up 34.27% from a year prior.
  • Debt Ratio hit 1.47 in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from 1.48 in the prior quarter.
  • Over the last five years, Debt Ratio for IRWD hit a ceiling of 1.7 in Q2 2025 and a floor of 0.1 in Q4 2021.
  • Historically, Debt Ratio has averaged 0.91 across 5 years, with a median of 1.06 in 2023.
  • Biggest five-year swings in Debt Ratio: rose 2.64% in 2024 and later surged 58.61% in 2025.
  • Tracing IRWD's Debt Ratio over 5 years: stood at 0.1 in 2021, then increased by 7.33% to 0.11 in 2022, then soared by 852.8% to 1.06 in 2023, then grew by 3.46% to 1.1 in 2024, then skyrocketed by 34.27% to 1.47 in 2025.
  • Business Quant data shows Debt Ratio for IRWD at 1.47 in Q4 2025, 1.48 in Q3 2025, and 1.7 in Q2 2025.